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Streszczenie
Wstęp. Nadciśnienie tętnicze (HTN) jest częstą przyczyną rozwoju zaburzeń czynności poznawczych. Aktualne 
dane podkreślają rolę HTN w niekorzystnej przebudowie naczyń i promowaniu zmian w obrębie mikrokrążenia 
mózgowego, prowadzących do upośledzenia funkcji poznawczych. W prezentowanym badaniu szukaliśmy związku 
między dobową zmiennością ciśnienia tętniczego (BPV) z wykorzystaniem 24-h ambulatoryjnego monitorowania 
ciśnienia tętniczego (ABPM) a zaburzeniami funkcji poznawczych u pacjentów w średnim wieku obciążonych na-
dciśnieniem tętniczym.
Materiał i metody. Grupę badaną stanowiło 42 pacjentów z niepowikłanym nadciśnieniem tętniczym (24 kobiety, 
18 mężczyzn, średni wiek: 59,1 ± 6,1 r.). BPV oceniono za pomocą ABPM i wyrażono w odchyleniu standardowym 
(24 MAP SD) i znormalizowanym względnym współczynniku zmienności (CV). Sprawność funkcji poznawczych 
oceniono z wykorzystaniem Krótkiej Skali Oceny Stanu Psychicznego (MMSE, Mini-Mental State Examination), 
Testu Rysowania Zegara (CDT, Clock Drawing Test), Montrealskiej Skali Oceny Funkcji Poznawczych (MoCA, 
Montreal Assessment Cognitive Scale).
Wyniki. W całej grupie badanej wyniki MMSE i CDT mieściły się w zakresie prawidłowym, jedynie w teście MoCA 
średnie wartości pozostawały poniżej przyjętej normy. Wyniki testów neuropsychologicznych były porównywalne 
dla grup z prawidłowym i nieprawidłowym (bez spadku nocnego) dobowym profilem BP. Spośród analizowanych 
parametrów BPV CV ujemnie korelował z wynikami CDT oraz MoCA. Podobnie, 24 MAP wyrażone odchyleniem 
standardowym korelowało ujemnie z wynikami CDT. W analizie wieloczynnikowej z uwzględnieniem wieku, płci, 
poziomu wykształcenia oraz zaburzeń lipidowych wyniki testu MoCA były odwrotnie skorelowane z CV. Średnie 
wyniki w teście MoCA były istotnie niższe u mężczyzn w porównaniu do kobiet.
Wnioski. W badaniu pilotażowym, łagodne upośledzenie funkcji poznawczych u chorych z wieloletnim, niepo-
wikłanym nadciśnieniem tętniczym może być związane ze zwiększoną dobową zmiennością ciśnienia tętniczego. 
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Abstract
Introduction. Hypertension (HTN) is a common cause of cognitive dysfunction. Current data emphasize a role of 
HTN in the development of unfavourable vascular remodelling and changes in cerebral microcirculation, leading 
to cognitive decline. In this study, we sought associations between circadian blood pressure variability (BPV) in  
a 24h blood pressure ambulatory monitoring (ABPM) and cognitive decline in middle-aged hypertensive patients. 
Material and methods. The study group comprised 42 patients with uncomplicated hypertension (24 females, 
18 males; mean age: 59.1 ± 6.1 years). BPV was assessed by ABPM and expressed in standard deviation (24 MAP 
SD) and coefficient of variation (CV). Cognitive performance was evaluated using Mini-Mental State Examination 
(MMSE), Clock Drawing Test (CDT) and Montreal Assessment Cognitive Scale (MoCA).
Results. In the whole study group, MMSE and CDT scores were within the normal range, but the mean scores were 
lowered in the MoCA test. All of the neuropsychological test scores were comparable in groups with normal and 
abnormal (non-dipper) blood pressure patterns. Among the analyzed BPV indicators, CV was negatively correlated 
with CDT and MoCA scores. 24 MAP expressed in standard deviations was also negatively correlated with CDT 
scores. In the multivariate analysis, MoCA scores were inversely associated with CV after adjusting for age, gender, 
education and abnormal lipid profiles. Mean MoCA scores were significantly lower in men in comparison to women.
Conclusions. In this pilot-based study, mild cognitive impairment in middle-aged patients with long-lasting un-
complicated hypertension may be associated with increased diurnal variability of blood pressure.
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Introduction
As a consequence of demographic changes related 
to population ageing, cerebrovascular mortality be-
comes a significant and increasing healthcare prob-
lem. Currently, cerebrovascular disease is the third 
most frequent cause of death in Poland. In addition, 
it is also one of the most frequent causes of cognitive 
dysfunction and vascular dementia (VD) [1–4]. 
Although the pathogenesis of small vessel disease 
has not been fully understood, an increasing body of 
evidence suggests a role of elevated blood pressure 
in the development of small vessel disease in the 
network of cerebral arteries [5, 6]. Arterial hyper-
tension (HTN) influence vascular remodelling and 
progress of atherosclerosis with ageing leading to 
hypoperfusion of the central nervous system and, as 
consequence, to the development of ischemic lesions, 
lacunar strokes and damage of the white matter [7]. 
Additionally, recent studies have emphasized the po-
tential role of the cerebral renin-angiotensin-aldoste-
rone system (RAAS) in the development of VD and 
cognitive disorders. RAAS has been found to have an 
impact on the control of cerebral blood flow, local 
oxidative processes, and the course of local inflam-
matory response [1, 8]. 
Currently, a close relationship has been well es-
tablished between HTN and dementia in the elder-
ly. However, some cross-sectional studies suggest an 
adverse effect of hypertension on cognitive functions 
also in the younger age groups [9–11]. Earlier reports 
demonstrated that accumulated blood pressure load 
proportionally increase the risk of cerebrovascular 
complications including VD [12–20], and the en-
hanced analysis of conventional 24-hour ambulatory 
blood pressure monitoring (ABPM) data may be 
useful in predicting cardio- and cerebrovascular out-
comes [21–25]. It has been showed that the assess-
ment of short-term systolic blood pressure variability 
(BPV) and pulse pressure (PP) substantially increase 
the prognostic value of data derived from conven-
tional ABPM [26]. There have been only a few data 
in the available literature on the relationship between 
BPV and cognitive impairment but they yielded in-
conclusive results [27–29].
In this pilot study, we aimed to assess the associ-
ation between BPV and cognitive function in mid-
dle-aged patients with uncomplicated primary HTN.
Material and methods
Study population
The study group comprised 42 patients (24 females, 
18 males) aged 45–70 years with spontaneous and 
uncomplicated hypertension who were referred to 
the Department of Hypertension & Internal Dis-
eases in Szczecin from November 2017 to March 
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2018 (inclusive). In reference to medical standards, 
secondary hypertension was excluded based on the 
routine biochemical and hormonal test and radiolo-
gical imaging. The study protocol was approved by 
the Bioethical Committee at the Pomeranian Me-
dical University in Szczecin (KB-0012/53/18). All 
subjects participating in the study gave their written 
informed consent.
24-h ABPM protocol
In all cases, a 24-hour ABPM was performed using 
Spacelabs 90207 device. Automatic measurements 
were taken every 20 minutes during the day and 
every 30 min during the night. Hours from 6.00 to 
22.00 were set as a daytime and from 22.00 to 6.00 
as a nocturnal period. We analyzed 24-hour, daytime 
and nocturnal systolic, diastolic and mean blood pres-
sure (24SBP, 24DBP, 24MAP, SBPd, DBPd, MAPd; 
SBPn, DBPn and MAPn, respectively), and nocturnal 
fall in systolic blood pressure. According to current 
guidelines [30], dipping blood pressure profile was 
defined as a reduction of at least 10% in overnight 
blood pressure; non-dipping as a decline less than 
10%: extreme-dipping as a decline above 20%, and 
reverse dipping if blood pressure was higher at night. 
As an additional indicator of the short-term circadian 
blood pressure variations, a 24-hour pulse pressure 
(PP) and 24-hour mean blood pressure variability 
expressed in standard deviation (24MAP SD) and 
coefficient of variation (CV) were calculated.
Assessment of cognitive impairment
Cognitive impairment was assessed by using the 
following neuropsychological diagnostic tests: 
Mini-Mental State Examination (MMSE), Clock 
Drawing Test (CDT), and Montreal Assessment 
Cognitive Scale (MoCA). The MMSE is a 30-item 
questionnaire that examines functions including 
registration (repeating named prompts), recall, at-
tention, orientation to time, language use, and the 
ability to follow simple commands. It is widely used 
to differentiate various types of dementias. The CDT 
is a valid complimentary tool to MMSE in the assess-
ment of cognitive impairment severity. The MoCA is 
a 30-point test assessing multiple cognitive domains 
and is known as a sensitive tool for detecting mild 
cognitive impairments. MMSE 27–30, CDT ≥ 6, 
MoCA ≥ 26 scores were assumed as reference values 
corresponding to the norm.
Statistical analysis
Descriptive statistics included frequency distribu-
tion for categorical variables and means, standard 
deviation, and range for continuous variables. The 
Kolmogorov-Smirnov test, unpaired Student’s t-test, 
Chi-square test, Spearman’s rank correlation, and 
ANCOVA were used to compute differences between 
groups and to test the associations between study 
variables. Statistical analyses were performed using 
STATISTICA Version 12 (StatSoft Inc.). 
Results
Baseline descriptive statistics are given in Table I. 
The mean age of the study group was 59.1 ± 6.1 
years (mean ± SD). Mean BMI was 29.5 kg/m2 but 
only 8 patients (19% of all cases) had BMI below 
25.0 kg/m2; the remaining were overweight or obese. 
Over half of them (64.3%) declared their education 
at least at the secondary level. There was a high 
prevalence of smokers (59.5%), and patients with 
dyslipidemia (57.1%) and abnormal glucose toler-
ance (30.9%). The total duration of HTN was 12.6 
± 11.2 years. Positive family history of hypertension 
was reported by 71.4% of respondents. Mean results 
of cognitive tests were within the normal range: 7.9 ± 
2.0 scores in CDT and 27.6 ± 1.8 scores in MMSE. 
Only in the MoCA test, mean scores were below the 
reference range (24.9 ± 2.5 scores). 
In the ABPM analysis, mean values of 24-hour 
systolic, diastolic and MAP pressure were 125.6 ± 
13.5, 75.9 ± 9.8 and 92.9 ± 9.8 mm Hg, respectively 
(Table II). Dipping blood pressure profile was found 
in 37%, non-dipping in 61% and reverse-dipping in 
2% of patients. Mean BPV was 12.2% which corre-
sponded to 11.4 SD. 
The results of neuropsychological tests were com-
parable between groups with normal and abnormal 
blood pressure profile (Table III). Among the ana-
lyzed BPV indicators, CV was inversely correlated 
with CDT (r = –0.37; p = 0.03) and MoCA (r = 
–0.36; p = 0.02), while SD was correlated only with 
CDT (r = –0.41; p = 0.02). 
In multivariate analysis, after adjustment for in-
cluding age, sex, education level and coexistence of 
abnormal lipid profiles (defined as the occurrence 
of at least one abnormality within LDL-cholesterol, 
HDL-cholesterol, and triglycerides levels), MoCA 
score was inversely associated with CV (b = –0.41; 
p = 0.02). Overall, males had significantly lower MoCA 
scores in comparison with females (p = 0.03) (Fig. 1). 
Discussion
The relationship among hypertension and cogni-
tive function is complex, albeit has not been fully 
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Table I. Clinical characteristic of the studied group. Data presented as means ± SD or percent; P-values for unpaired t-tests or chi-square 
test, respectively
All
n = 42
Females
n = 24
Males
n = 18
P-value ¶F 
vs. M
Anthropometrics:
Age [years] 59.1 ± 6.1 60.1 ± 6.1 57.8 ± 6.1 0.24
Body mass index [kg/m2] 29.8 ± 5.6 28.7 ± 4.3 31.2 ± 6.9 0.16
Office Blood Pressure:
Systolic blood pressure [mm Hg] 147.2 ± 25.0 145.1 ± 20.3 149.7 ± 30.1 0.58
Diastolic blood pressure [mm Hg] 91.4 ± 12.9 88.1 ± 10.0 95.3 ± 15.0 0.08
Mean blood pressure [mm Hg] 110.0 ± 15.6 107.1 ± 11.7 113.4 ± 19.0 0.21
Laboratory tests:
Fasting blood glucose [md/dL] 100.1 ± 18.1 99.4 ± 13.3 101.1 ± 23.6 0.76
Above 100 mg/dl (%) 31.0% 33.3% 27.8% 0.70
LDL-cholesterol [mg/dL] 112.1 ± 41.2 113.4 ± 45.8 110.5 ± 35.8 0.82
Above 100 mg/dl (%) 54.8% 54.2% 55.6% 0.93
HDL-cholesterol [mg/dL] 54.7 ± 18.8 60.2 ± 21.6 47.6 ± 11.6 0.03
Below 40 (males) or 45 (females) [mg/dl] (%) 33.3% 37.5% 27.8% 0.51
Triglycerides [mg/dL] 132.4 ± 63.0 144.8 ± 76.4 116.5 ± 35.9 0.15
Above 150 [mg/dl] (%) 31.0% 41.7% 16.7% 0.08
Medical history
Hypertension duration [months] 12.6 ± 11.2 14.4 ± 12.0 10.3 ± 9.8 0.24
Smokers (%) 59.5% 62.5% 55.6% 0.65
Family history of hypertension (%) 71.4% 79.2% 61.1% 0.20
Primary education (%) 14.3% 12.5% 16.7% 0.70
Secondary education (%) 52.4% 62.5% 38.9% 0.13
Higher education (%) 33.3% 25.0% 44.4% 0.19
Neurocognitive tests:
CDT [scores] 7.9 ± 2.0 8.0 ± 2.0 7.9 ± 2.1 0.85
MMSE [scores] 27.6 ± 1.8 27.8 ± 1.6 27.4 ± 2.1 0.44
MoCA [scores] 24.9 ± 2.5 25.5 ± 2.2 24.2 ± 2.7 0.08
CDT — Clock Drawing Test; MMSE — Mini-Mental State Examination; MoCA — Montreal Assessment Cognitive Scale
understood yet. An impact of midlife hypertension on 
the development of cognitive impairment has been 
recently extensively studied and there is growing ev-
idence that elevated blood pressure is the most pow-
erful among modifiable risk factors for cerebral vessel 
dysfunction that contribute to cognitive decline in 
later life [15, 31–36]. Numerous studies addressed 
this issue to specific blood pressure cut-offs, or more 
recently — exclusively to systolic blood pressure va-
lues [13, 14, 16, 31]. In this pilot study, we investi-
gated a potential role of short-term blood pressure 
variations in cognitive impairments. 
In clinical practice, ABPM is a method that allows 
not only to evaluate the effectiveness of antihyper-
tensive therapy but also highly useful in predicting 
cardiovascular risk in patients with hypertension 
[37–41]. ABPM provides valuable information on 
the circadian variability of blood pressure and blood 
pressure patterns, which have been shown to be pre-
dictive for cognitive function [21, 42, 43]. Clinical 
studies in humans have demonstrated the strong 
association of cognitive impairment and VD with 
non-dipping, reverse-dipping and, extreme-dipping 
blood pressure patterns diagnosed by conventional 
24-hour ABPM [22–25].
In our study, we found the presence of a non-dip-
ping pattern in over 60% of patients. However, we 
did not find any differences in the neuropsycho-
logical test scores between the groups with normal 
and non-dipping pattern. A vast majority of studies 
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Table II. Blood pressure values and circadian variability (24 hour 
ABPM)
Blood pressure Mean (± SD) 
24SBP [mm Hg] 125.6 ± 13.5 
24DBP [mm Hg] 75.9 ± 9.8 
24MAP [mm Hg] 92.9 ± 9.8 
SBPd [mm Hg] 128.1 ± 14.2 
DBPd [mm Hg] 78.3 ± 10.2 
MAPd [mm Hg] 95.1 ± 10.3 
SBPn [mm Hg] 118.1 ± 13.6 
DBPn [mm Hg] 69.9 ± 8.8 
MAPn [mm Hg] 87.1 ± 8.9 
CV [%] 12.2 ± 3.1 
24MAP SD [mm Hg] 11.4 ± 3.2 
PP [mm Hg] 49.7 ± 9.1 
Dippers (%) 36.6%
Non-dippers (%) 61.0%
Reverse-dippers (%) 2.4%
24SBP — 24-hour Systolic Blood Pressure; 24DBP — 24-hour Diastolic Blood Pressure; 24MAP— 
24-hour Mean Blood Pressure; SBPd — Daytime Systolic Blood pressure; DBPd — Daytime Diastolic 
Blood Pressure; MAPd — Daytime Mean Blood Pressure; SBPn — Nocturnal Systolic Blood Pressure; 
DBPn — Nocturnal Diastolic Blood Pressure; MAPn — Nocturnal Mean Blood Pressure; CV — Co-
efficient of Variation; 24 MAP SD — 24-hour Mean Blood Pressure Variability Estimated by Standard 
Deviation; PP — pulse pressure
Table III. The relationship between blood pressure variability and pulse pressure with neuropsychological test scores
ABPM variable Cognitive test R P-value
CV [%] CDT –0.37 0.03
MMSE –0.13 0.44
MoCA –0.36 0.02
24 MAP SD [mm Hg] CDT –0.40 0.02
MMSE –0.08 0.64
MoCA –0.27 0.09
PP [mm Hg] CDT 0.02 0.91
MMSE 0.06 0.73
MoCA 0.13 0.41
CV — The Coefficient of Variation; 24MAP SD — 24-hour Mean Blood Pressure Variability (SD); PP — Pulse Pressure; CDT — Clock Drawing Test; MMSE — Mini-Mental State Examination; MoCA — Montreal Assess-
ment Cognitive Scale; R — Spearman’s Rank Correlation Coefficient 
Figure 1. MoCA scores by gender adjusted for age — education 
level and lipid profiles
reporting such relationship suggested a potential 
role of secondary, hypertension-related the cerebral 
white matter lesions, higher frequency of lacunar 
infarction and reduction of total brain matter, which 
were strongly influenced by age [44–46]. In contrast 
to these reports, our study population was relatively 
younger and had no history of the symptomatic 
cerebrovascular disease. Furthermore, in contrast to 
the blood flow in other organs, cerebral blood flow 
increases during the night as a result of an increased 
oxygen demand [47]. Some authors suggest that in 
hypertensive patients a blunted reduction in noc-
turnal blood pressure may play an adaptive role in 
maintaining the night-time cerebral blood flow when 
autoregulatory mechanisms fail [48]. However, it 
seems unclear whether this adaptive mechanism is 
essential also in middle-aged patients without prior 
cerebrovascular events. 
It has been well documented that aside from the 
conventional 24-h ABPM analysis, the ABPM in-
dicators of short-term BPV may possess prognostic 
potential in the assessment of cerebrovascular risk 
[22, 26, 27, 49]. We found the scores in neuropsy-
chological tests were inversely correlated with 24-h 
SD and CV. Bellelli et al. [49] demonstrated the 
association between cognitive decline and increased 
24-hour BPV-CV in the elderly. They suggested 
that in hypertensive patients with the cognitive de-
cline the sympathetic nervous system affects short-
-term BPV and its activation may be related to 
impaired baroreceptor response. Further studies are 
arterial hypertension 2018, vol. 22, no. 3
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needed to elucidate whether this mechanism is also 
relevant in younger patients with uncomplicated 
hypertension.
We found significantly lower scores in the MoCA 
test in males in comparison to females. In the ge-
neral population, cognitive decline is more com-
mon in women than in men. This is explained 
mostly by the longer life span [50–53] as well as an 
impact of genetics factors, sex hormone changes in 
midlife, and lower cognitive reserve that results in 
faster cognitive decline in women [50, 54, 55]. On 
the other hand, other studies demonstrated that 
compared with females, males showed significantly 
worse performance in Assessment Scale-cognitive 
subscale 13 (ADAS) evaluating subjective cognitive 
decline [56]. These gender discrepancies may be re-
lated to differences in cognitive domains evaluated 
by various neuropsychological tests. In this study, 
we used the MoCA scale, which is more specific for 
the assessment of memory, executive functions and 
psychomotor performance [57]. The MoCA scores 
are typically worse in the vascular cognitive decline 
associated with hypertension [58–60]. Our results 
seem consistent with earlier studies reporting that 
males have faster memory decline due to the typi-
cally earlier onset of cardiovascular disease, includ-
ing primary hypertension [50, 61, 62].
Conclusions
In this a pilot-based study, mild cognitive impair-
ment in middle-aged patients with long-lasting un-
complicated hypertension may be associated with 
increased diurnal variability of blood pressure.
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